FDA Approved: ETODOLAC — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)

View source ↗

Summary

The FDA approved a supplemental application for etodolac by Taro Pharmaceuticals U.S.A., Inc. under the ANDA program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Etodolac (Etodolac)

Snippet

SUPPL AP for ETODOLAC (ETODOLAC)